Early results from phase 3 trial look promising but there are still many questions to be answered
Pfizer and the German biotech company Biontech said on Monday that they had had encouraging early results from a phase 3 clinical trial of their coronavirus vaccine. The trial is assessing how well the vaccine works in preventing humans from becoming infected. Although details are scant, the news is positive.
Related: Covid vaccine tracker: when will a coronavirus vaccine be ready?
